News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
It was a great opportunity to share the innovation initiatives coming out of Penn and Philadelphia with a global audience.
This in-depth interview with Swartley provides a comprehensive history about technology transfer at Penn as well as the establishment and current success of PCI.
the Mitchell Lab has developed a new class of anisimide-functionalized lipids that enables targeted delivery of lipid nanoparticles (LNPs) to activated fibroblasts in the liver.
Penn officially ranked number one in terms of licensing income in the latest Association of University Technology Managers (AUTM) annual survey, which included 153 reporting institutions.
The PCI Technology Publisher website recently added a new subscription feature so that you can receive email updates about new technologies from particular inventors, categories, and departments.
Ellie Weinstein, Pennovation Accelerator alumni, developed the Cocoa Press to 3D print chocolate.
The CEO Council for Growth recently highlighted PCI's annual review and JP Morgan Conference event in its newsletter.
This technology is an intracerebral drug delivery system that consists of three flexible, retractable microcannulas housed within a single central catheter.
PCI supported Penn spinouts Interius BioTherapeutics, Verismo Therapeutics, viTToria biotherapeutics, Exyn Technologies, and Avisi Technologies are all nominated for awards.